Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Bone|April 7, 2017
Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnoverCasey J Droscha, Cassandra R Diegel, Nicole J Ethen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2011
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomasBrendan D Looyenga, Kyle A Furge, Karl J Dykema, et al.
Endocrine-Related Cancer|December 23, 2009
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumorsMichael A Hahn, Viive M Howell, Anthony J Gill, et al.
American Journal of Translational Research|December 8, 2009
Microarray gene expression profiling using core biopsies of renal neoplasiaCraig G Rogers, Jonathon A Ditlev, Min-Han Tan, et al.
The American Journal of Pathology|October 9, 2002
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidismTrisha Dwight, Anne E Nelson, George Theodosopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patientsJan Akervall, Xiang Guo, Chao-Nan Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancerStephan Macher-Goeppinger, Sebastian Aulmann, Katrin E Tagscherer, et al.
Molecular Cancer Therapeutics|May 27, 2010
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft studyHans J Hammers, Henk M Verheul, Brenda Salumbides, et al.
The American Journal of Pathology|February 2, 2011
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinomaFrederik C Roos, Andrew J Evans, Walburgis Brenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinomaYoun-Soo Lee, Alexander O Vortmeyer, Irina A Lubensky, et al.
Pageof 6